These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 10096421

  • 1. Enhancement of urinary bladder carcinogenesis in nullizygous p53-deficient mice by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Yamamoto S, Min W, Lee CC, Salim EI, Wanibuchi H, Sukata T, Fukushima S.
    Cancer Lett; 1999 Jan 29; 135(2):137-44. PubMed ID: 10096421
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. High susceptibility of p53(+/-) knockout mice in N-butyl-N-(4-hydroxybutyl)nitrosamine urinary bladder carcinogenesis and lack of frequent mutation in residual allele.
    Ozaki K, Sukata T, Yamamoto S, Uwagawa S, Seki T, Kawasaki H, Yoshitake A, Wanibuchi H, Koide A, Mori Y, Fukushima S.
    Cancer Res; 1998 Sep 01; 58(17):3806-11. PubMed ID: 9731488
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Genetic instability and p53 mutations in metastatic foci of mouse urinary bladder carcinomas induced by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Yamamoto S, Chen T, Murai T, Mori S, Morimura K, Oohara T, Makino S, Tatematsu M, Wanibuchi H, Fukushima S.
    Carcinogenesis; 1997 Oct 01; 18(10):1877-82. PubMed ID: 9363994
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Clonal analysis of urothelial carcinomas in C3H/HeN<-->BALB/c chimeric mice treated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Yamamoto S, Tatematsu M, Yamamoto M, Fukami H, Fukushima S.
    Carcinogenesis; 1998 May 01; 19(5):855-60. PubMed ID: 9635874
    [Abstract] [Full Text] [Related]

  • 12. The interaction of arsenic and N-butyl-N-(4-hydroxybutyl)nitrosamine on urothelial carcinogenesis in mice.
    Dai YC, Wang SC, Haque MM, Lin WH, Lin LC, Chen CH, Liu YW.
    PLoS One; 2017 May 01; 12(10):e0186214. PubMed ID: 29016672
    [Abstract] [Full Text] [Related]

  • 13. Reduced expression of the CDK inhibitor p27(KIP1) in rat two-stage bladder carcinogenesis and its association with expression profiles of p21(WAF1/Cip1) and p53.
    Lee CC, Ichihara T, Yamamoto S, Wanibuchi H, Sugimura K, Wada S, Kishimoto T, Fukushima S.
    Carcinogenesis; 1999 Sep 01; 20(9):1697-708. PubMed ID: 10469613
    [Abstract] [Full Text] [Related]

  • 14. Accelerated induction of bladder cancer in patched heterozygous mutant mice.
    Hamed S, LaRue H, Hovington H, Girard J, Jeannotte L, Latulippe E, Fradet Y.
    Cancer Res; 2004 Mar 15; 64(6):1938-42. PubMed ID: 15026327
    [Abstract] [Full Text] [Related]

  • 15. p53 mutations in early neoplastic lesions of the urinary bladder in rats treated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Masui T, Don I, Takada N, Ogawa K, Shirai T, Fukushima S.
    Carcinogenesis; 1994 Oct 15; 15(10):2379-81. PubMed ID: 7955081
    [Abstract] [Full Text] [Related]

  • 16. Susceptibility of p27 kip1 knockout mice to urinary bladder carcinogenesis induced by N-butyl-N-(4-hydroxybutyl)nitrosamine may not simply be due to enhanced proliferation.
    Hikosaka A, Ogawa K, Sugiura S, Asamoto M, Takeshita F, Sato SY, Nakanishi M, Kohri K, Shirai T.
    Int J Cancer; 2008 Mar 15; 122(6):1222-8. PubMed ID: 18027869
    [Abstract] [Full Text] [Related]

  • 17. Cyclin D1 overexpression in rat two-stage bladder carcinogenesis and its relationship with oncogenes, tumor suppressor genes, and cell proliferation.
    Lee CC, Yamamoto S, Wanibuchi H, Wada S, Sugimura K, Kishimoto T, Fukushima S.
    Cancer Res; 1997 Nov 01; 57(21):4765-76. PubMed ID: 9354438
    [Abstract] [Full Text] [Related]

  • 18. Alterations of beta- and gamma-catenin in N-butyl-N-(-4-hydroxybutyl)nitrosamine-induced murine bladder cancer.
    Shiina H, Igawa M, Urakami S, Shigeno K, Yoneda T, Terashima M, Deguchi M, Ribeiro-Filho L, Dahiya R.
    Cancer Res; 2001 Oct 01; 61(19):7101-9. PubMed ID: 11585741
    [Abstract] [Full Text] [Related]

  • 19. Frequent p53 mutations and occasional loss of chromosome 4 in invasive bladder carcinoma induced by N-butyl-N-(4-hydroxybutyl)nitrosamine in B6D2F1 mice.
    Ogawa K, Uzvolgyi E, St John MK, de Oliveira ML, Arnold L, Cohen SM.
    Mol Carcinog; 1998 Jan 01; 21(1):70-9. PubMed ID: 9473773
    [Abstract] [Full Text] [Related]

  • 20. Low susceptibility of nude mice to induction of invasive urinary bladder cancers by N-ethyl-N-(4-hydroxybutyl)nitrosamine.
    Tamano S, Shirai T, Kawabe M, Ni-I H, Mori Y, Okada M, Fukushima S.
    Toxicol Pathol; 1992 Jan 01; 20(2):205-11. PubMed ID: 1475581
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.